Briggs Morrison
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Briggs Morrison
Briggs Morrison is recorded as CEO at Schneider National, Inc. (SNDR). Briggs Morrison was last confirmed as CEO at Syndax Pharmaceuticals Inc (SNDX) in a filing dated April 7, 2023. The proxy statement of Syndax Pharmaceuticals Inc reports total compensation of $2,374,171 for Briggs Morrison in fiscal 2022, including a base salary of $637,500. Disclosed compensation is on record for 3 fiscal years. Briggs Morrison has spoken on 12 earnings calls across 1 company, most recently for Syndax Pharmaceuticals Inc on February 28, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2023-04-07
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Schneider National, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher B. Lofgren CEO
- James S. Filter CEO, Board Member
- James L. Welch Chairman, Board Member
- Mark B. Rourke Chairman, Board Member
- Darrell Campbell CFO
- Shaleen Devgun CIO
- Shelly Dumas Magnin Chief Accounting Officer
- Austin M. Ramirez Board Member
- James R. Giertz Board Member
- John A. Swainson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of Research and Development and Former Chief Executive Officer | $637,500 | $2,374,171 |
| 2021 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of Research and Development and Former Chief Executive Officer | $618,563 | $3,904,316 |
| 2020 | Syndax Pharmaceuticals Inc (SNDX) | President, Head of Research and Development and Former Chief Executive Officer | $600,547 | $2,165,397 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.